IE 11 is not supported. For an optimal experience visit our site on another browser.
  • UP NEXT

    Data may be best defense against new attacks on maternal health program for Black women

    05:30

  • 'There is no funding for abortion' in AIDS program...It's pro-life,' says senator

    08:56

  • Women harmed by Texas anti-abortion law take fight to state supreme court

    04:26

  • More women denied abortions in Texas join lawsuit against the state 

    06:48

  • 'Periodical' aims to de-stigmatize menstruation and menopause

    02:41

  • Senator identifies 'Insulin Deserts' in new report calling for lower drug costs

    07:30

  • Thundergong benefit concert set to bang into Kansas City

    09:12

  • Successful PEPFAR AIDS program in jeopardy

    02:37

  • 'People were paying attention': Ohio voters overcome GOP obfuscation to enshrine abortion rights

    04:15

  • Republicans resort to lies and deception ahead of vote on popular abortion rights amendment in Ohio

    07:59

  • 'It lasts longer, it starts earlier': Experts explain puberty

    06:46

  • Inside the fight to end period poverty

    04:36

  • How a shutdown could impact health care for veterans

    03:36

  • ‘They’re obsessed’: Dr. Fauci on death threats, 'lab leak,' and vaccine safety

    27:57

  • Melinda French Gates: investing in health systems in impoverished places will bring ‘less conflict’

    06:23

  • Struggles with self-doubt at the heart of 'Unreliable Narrator'

    07:35

  • Growing concerns about hospice fraud

    07:13

  • Preparation for the next pandemic relies on persuasion, says author

    07:24

  • Common over-the-counter decongestant does not work, FDA panel says

    03:16

  • 'Richer, wealthier and happier': The future of AI and its impact on humanity

    06:21

All In

Outrage over EpiPen price increase

02:38

Chris Hayes explains the growing controversy surrounding Mylan Pharmaceuticals and its signature, life-saving product: the EpiPen. Hillary Clinton is calling the latest price hike on the EpiPen 'outrageous,' but the company has at least one defender.Aug. 25, 2016

  • UP NEXT

    Data may be best defense against new attacks on maternal health program for Black women

    05:30

  • 'There is no funding for abortion' in AIDS program...It's pro-life,' says senator

    08:56

  • Women harmed by Texas anti-abortion law take fight to state supreme court

    04:26

  • More women denied abortions in Texas join lawsuit against the state 

    06:48

  • 'Periodical' aims to de-stigmatize menstruation and menopause

    02:41

  • Senator identifies 'Insulin Deserts' in new report calling for lower drug costs

    07:30

MSNBC HIGHLIGHTS

Play All
Play All